Literature DB >> 28727287

Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list.

Ani A Kardashian1, Jennifer L Dodge2, John Roberts2, Danielle Brandman3.   

Abstract

BACKGROUND & AIMS: Obesity is a growing problem in liver transplant (LT) candidates, paralleling the US obesity epidemic and increase in LT for non-alcoholic steatohepatitis (NASH). While post-LT survival appears to be similar in obese and non-obese patients, data are scarce regarding risk of waitlist dropout in patients with morbid obesity (BMI ≥ 40 kg/m2 ). We examined the impact of obesity on waitlist mortality and evaluated predictors of dropout in LT candidates with morbid obesity or NASH.
METHODS: Competing risk analyses were performed in candidates listed between 3/2002-12/2013 to evaluate predictors of waitlist removal or death. Variables with P-value <.05 in univariable models or clinically relevant were included in multivariable models.
RESULTS: Eighty-four thousand two hundred and fifty-four patients (34% female, median age 55, 15% Hispanic) were included. Compared to those with BMI 25-29.9 kg/m2 , candidates with BMI ≥ 40 kg/m2 were more likely to be female (46% vs 28%), diabetic (25% vs 18%) and have NASH (35% vs 13%); all P < .001. After adjusting for well-recognized predictors of waitlist dropout, including ascites severity, morbid obesity (HR = 1.27, CI 1.20-1.36) and diabetes (HR = 1.14, CI 1.11-1.17) were independent predictors of dropout. Morbid obesity remained a predictor (HR = 1.27, CI 1.10-1.47) of dropout in patients without ascites (24%). In NASH patients, morbid obesity (HR = 1.21, CI 1.07-1.37) and diabetes (HR = 1.15, CI 1.06-1.23) were also associated with a higher dropout risk. In patients with morbid obesity, diabetes trended towards a higher dropout risk but was not significant (HR = 1.12, CI 0.995-1.26).
CONCLUSIONS: Morbid obesity and diabetes are independent predictors of death in LT candidates.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetes; liver transplantation; obesity; waitlist

Mesh:

Year:  2017        PMID: 28727287     DOI: 10.1111/liv.13523

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

Review 1.  Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  Iliana Doycheva; Paul J Thuluvath
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 2.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 3.  Evaluation of liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  James Philip G Esteban; Amon Asgharpour
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 4.  Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

Authors:  Naga Swetha Samji; Rajiv Heda; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05

5.  Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain.

Authors:  Daiki Soma; Yujin Park; Plamen Mihaylov; Burcin Ekser; Marwan Ghabril; Marco Lacerda; Naga Chalasani; Richard S Mangus; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2022-01-05

6.  Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study.

Authors:  Claire Delacôte; Mathilde Favre; Medhi El Amrani; Massih Ningarhari; Elise Lemaitre; Line Carolle Ntandja-Wandji; Pierre Bauvin; Emmanuel Boleslawski; Guillaume Millet; Stephanie Truant; Philippe Mathurin; Alexandre Louvet; Valérie Canva; Gilles Lebuffe; François René Pruvot; Sébastien Dharancy; Guillaume Lassailly
Journal:  United European Gastroenterol J       Date:  2022-04-26       Impact factor: 6.866

7.  Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study.

Authors:  Fakhar Ali Qazi-Arisar; Raj Uchila; Catherine Chen; Cathy Yang; Shi-Yi Chen; Ravikiran Sindhuvalada Karnam; Amirhossein Azhie; Wei Xu; Zita Galvin; Nazia Selzner; Leslie Lilly; Mamatha Bhat
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

Review 8.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

Review 9.  Obesity in the Liver Transplant Setting.

Authors:  Carlos Moctezuma-Velazquez; Ernesto Márquez-Guillén; Aldo Torre
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.